130 related articles for article (PubMed ID: 10398280)
1. Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistance.
Davol PA; Frackelton AR
Prostate; 1999 Aug; 40(3):178-91. PubMed ID: 10398280
[TBL] [Abstract][Full Text] [Related]
2. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
3. The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model.
Davol P; Frackelton AR
J Urol; 1996 Sep; 156(3):1174-9. PubMed ID: 8709341
[TBL] [Abstract][Full Text] [Related]
4. Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model.
Davol PA; Garza S; Frackelton AR
Cancer; 1999 Nov; 86(9):1733-41. PubMed ID: 10547546
[TBL] [Abstract][Full Text] [Related]
5. Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model.
Davol P; Beitz JG; Mohler M; Ying W; Cook J; Lappi DA; Frackelton AR
Cancer; 1995 Jul; 76(1):79-85. PubMed ID: 8630880
[TBL] [Abstract][Full Text] [Related]
6. Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell line.
Davol P; Beitz JG; Frackelton AR
J Invest Dermatol; 1995 Jun; 104(6):916-21. PubMed ID: 7769258
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
Miller K; Wilder PJ; Rizzino A
Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
[TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations.
Reiland J; Rapraeger AC
J Cell Sci; 1993 Aug; 105 ( Pt 4)():1085-93. PubMed ID: 8227197
[TBL] [Abstract][Full Text] [Related]
11. The basic fibroblast growth factor-saporin mitotoxin impairs in vivo skeletal regeneration following injury.
Lefaucheur JP; Sébille A
Neuromuscul Disord; 1993; 3(5-6):367-70. PubMed ID: 8186677
[TBL] [Abstract][Full Text] [Related]
12. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
Ying W; Martineau D; Beitz J; Lappi DA; Baird A
Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.
Song S; Wientjes MG; Gan Y; Au JL
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8658-63. PubMed ID: 10890892
[TBL] [Abstract][Full Text] [Related]
14. Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines.
Ogasawara S; Yano H; Iemura A; Hisaka T; Kojiro M
Hepatology; 1996 Jul; 24(1):198-205. PubMed ID: 8707262
[TBL] [Abstract][Full Text] [Related]
15. The biologic effects of growth factor-toxin conjugates in models of vascular injury depend on dose, mode of delivery, and animal species.
Yu C; Cunningham M; Rogers C; Dinbergs ID; Edelman ER
J Pharm Sci; 1998 Nov; 87(11):1300-4. PubMed ID: 9811480
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
[TBL] [Abstract][Full Text] [Related]
17. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
Lappi DA; Maher PA; Martineau D; Baird A
J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
[TBL] [Abstract][Full Text] [Related]
18. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
Tetzke TA; Caton MC; Maher PA; Parandoosh Z
Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
[TBL] [Abstract][Full Text] [Related]
19. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
[TBL] [Abstract][Full Text] [Related]
20. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo.
Gross JL; Herblin WF; Dusak BA; Czerniak P; Diamond MD; Sun T; Eidsvoog K; Dexter DL; Yayon A
J Natl Cancer Inst; 1993 Jan; 85(2):121-31. PubMed ID: 8418301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
